Free Trial
OTC:ACOGF

Alpha Cognition (ACOGF) Stock Price, News & Analysis

Alpha Cognition logo

About Alpha Cognition Stock (OTC:ACOGF)

Key Stats

Today's Range
N/A
50-Day Range
C$0.35
C$9.44
52-Week Range
N/A
Volume
179,500 shs
Average Volume
78,954 shs
Market Capitalization
C$52.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Alpha Cognition Inc., a clinical stage biopharmaceutical company, develops treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and mild traumatic brain injury; ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.

Receive ACOGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpha Cognition and its competitors with MarketBeat's FREE daily newsletter.

ACOGF Stock News Headlines

Do this Before Elon’s Reveal on January 22nd
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.
Alpha Cognition Inc Ordinary Shares
Alpha Cognition Inc
See More Headlines

ACOGF Stock Analysis - Frequently Asked Questions

Alpha Cognition Inc. (OTC:ACOGF) released its quarterly earnings results on Monday, August, 12th. The company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.04) by $0.03.

Shares of ACOGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Last Earnings
8/12/2024
Today
12/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$-13,770,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
C($0.04) per share

Miscellaneous

Free Float
103,306,000
Market Cap
C$52.80 million
Optionable
Not Optionable
Beta
2.80
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (OTC:ACOGF) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners